This has also diagnostic and therapeutic consequences: the detection of antibodies to AQP-4 is a highly suggestive marker for the autoimmune disorder neuromyelitis optica [53], while AQP-4 is recently considered a valuable target in treating cerebral edema [54]. The gene discussed is AQP4; the disease is neuromyelitis optica.